drugset / Trial / NCT07599865
Periprosthetic Joint Infection Bubble Study
Phase 2
Not yet recruiting
100 enrolled
Thomas Jefferson University
National Institute of Allergy and Infectious Diseases (NIAID) · collab
RandomizedSingle-groupOpen-labelTreatment
Summary
Patients with an infected knee replacement will receive their standard of care surgical treatment of the infection, with and without additional ultrasound microbubble treatment (randomly divided 50/50 in the active and control groups). Subjects in the active group will receive a local bolus injection of antibiotics and ultrasound-active microbubbles within 24 hours of their revision surgery. The fundamental hypothesis is that a decrease in re-infection rates of at least 24% can be achieved in the active group relative to controls.
Timeline
- Start
- 2026-06
- Primary completion
- 2028-06
- Completion
- 2030-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Definity | Diagnostic / imaging agent | — | Other |